or
forgot password
  • cancer clinical trials in stony brook, NY

  • Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Leukemia
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Bladder Cancer
    Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Endometrial Cancer
    Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Anemia, Cervical Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Toxicity
    Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
    State University of New York at Stony Brook School of Medicine
    Stony Brook, New York 11794-8706
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Brain and Central Nervous System Tumors
    Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Leukemia
    Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Endometrial Cancer
    Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Pancreatic Cancer
    Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
    University Hospital - Stony Brook
    Stony Brook, New York 11794-8174
    Pancreatic Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Brain and Central Nervous System Tumors
    Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Lymphedema, Perioperative/Postoperative Complications, Vulvar Cancer
    Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Cervical Cancer
    Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Sarcoma
    Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Sarcoma
    Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Kidney Cancer
    Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Cervical Cancer
    OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
    Stony Brook University Hospital
    Stony Brook, New York 11794-8174
    Pancreatic Cancer
    Vaginal Changes and Sexual Function in Patients With Cervical Cancer
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Cervical Cancer, Sexuality and Reproductive Issues
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Cervical Cancer
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Leukemia
    Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Lymphoma
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Vulvar Cancer
    Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Endometrial Cancer
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Brain Tumor, Central Nervous System Tumor
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Endometrial Cancer
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Lung Cancer
    Safety Study to Evaluate FluMist in Immunocompromised Children
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy
    Stony Brook University Hospital
    Stony Brook, New York 11794-8174
    Locally Recurrent or Metastatic Cancer of the Head and Neck, Must Have Failed First-Line Therapy
    A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies
    University Hospital Medical Center - SUNY at Stony Brook
    Stony Brook, New York 11794
    Cancer, Malignant Tumors
    Effects of Selenium and Vitamin E Supplements on Lung Function and Chronic Obstructive Pulmonary Disease
    SUNY Stony Brook
    Stony Brook, New York 11733
    Pulmonary Disease, Chronic Obstructive, Lung Diseases
    Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.
    SUNY Stony Brook
    Stony Brook, New York 11733
    Colon Cancer, Polyp, Adenoma
    3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
    University of New York at Stony Brook
    Stony Brook, New York
    HIV Infections
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Neuroblastoma
    Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Colorectal Cancer
    Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Lung Cancer
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Sarcoma
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Leukemia
    Chemoprevention of Colorectal Adenomas
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Adenomatous Polyps
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Cervical Cancer
    A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
    Department of Pediatrics, SUNY at Stony Brook
    Stony Brook, New York 11794-8111
    Chronic Idiopathic Thrombocytopenic Purpura
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    Stony Brook University Medical Center- Cancer Center
    Stony Brook, New York 11794-9446
    Melanoma
    Dasatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Ileus
    Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
    State University of NY Stony Brook
    Stony Brook, New York 11794
    Genital Warts
    Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Acute Myeloid Leukemia, AML
    Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
    DermResearchCenter of New York
    Stony Brook, New York 11790
    Actinic Keratosis
    A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    BIBF 1120 in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Endometrial Cancer
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Stony Brook University
    Stony Brook, New York 11794
    Locally Recurrent or Metastatic Breast Cancer
    Brivanib in Treating Patients With Persistent or Recurrent Cervical Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Cervical Cancer
    Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
    SUNY - Stony Brook University
    Stony Brook, New York 11794-8121
    Multiple Sclerosis
    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Gliosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Osteosarcoma